MLICM
BVS icon

Metropolitan Life Insurance Company (MetLife)’s Bioventus BVS Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,250
Closed -$15.8K – 2354
2022
Q3 		$15.8K Hold
2,250
– – ﹤0.01% 2134
2022
Q2 		$15.3K Hold
2,250
– – ﹤0.01% 2165
2022
Q1 		$31.7K Sell
2,250
-6,917
-75% -$92.6K ﹤0.01% 1850
2021
Q4 		$133K Buy
+9,167
New +$130K ﹤0.01% 2303

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s BVS Position: Q4 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Bioventus (BVS) in Q4 2022, closing a stake of 2,250 shares — an estimated $15.8K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in BVS in Q4 2021 and held it in 4 quarters. The position peaked at $133K in Q4 2021. 85 funds tracked by Wall St. Rank hold BVS as of Q4 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Bioventus position as of Q4 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,250 Bioventus shares in Q4 2022, an estimated $15.8K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Bioventus in Q4 2021 and held it in 4 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Bioventus position peaked at $133K in Q4 2021.
  • 85 funds tracked by Wall St. Rank held Bioventus as of Q4 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2022, filed 15 Feb 2023.